0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-itch Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-26S14382
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anti itch Drugs Market Research Report 2023
BUY CHAPTERS

Global Anti-itch Drugs Market Research Report 2025

Code: QYRE-Auto-26S14382
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-itch Drugs Market Size

The global market for Anti-itch Drugs was valued at US$ 3674 million in the year 2024 and is projected to reach a revised size of US$ 5011 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Anti-itch Drugs Market

Anti-itch Drugs Market

An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-itch Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-itch Drugs.
The Anti-itch Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-itch Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-itch Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-itch Drugs Market Report

Report Metric Details
Report Name Anti-itch Drugs Market
Accounted market size in year US$ 3674 million
Forecasted market size in 2031 US$ 5011 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Bayer, Sanofi, Combe Incorporated, CR SANJIU, Lingrui, Jinyao Pharma, Dinuo Pharma, Huapont, Medimetriks Pharmaceuticals, Taro Pharmaceutical, Teva, Sun Pharmaceutical, Perrigo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-itch Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-itch Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Anti-itch Drugs Market growing?

Ans: The Anti-itch Drugs Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Anti-itch Drugs Market size in 2031?

Ans: The Anti-itch Drugs Market size in 2031 will be US$ 5011 million.

Who are the main players in the Anti-itch Drugs Market report?

Ans: The main players in the Anti-itch Drugs Market are Johnson & Johnson, Bayer, Sanofi, Combe Incorporated, CR SANJIU, Lingrui, Jinyao Pharma, Dinuo Pharma, Huapont, Medimetriks Pharmaceuticals, Taro Pharmaceutical, Teva, Sun Pharmaceutical, Perrigo

What are the Application segmentation covered in the Anti-itch Drugs Market report?

Ans: The Applications covered in the Anti-itch Drugs Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Anti-itch Drugs Market report?

Ans: The Types covered in the Anti-itch Drugs Market report are Single Preparation, Compound Ointment

Recommended Reports

Dermatology Treatments

Itch & Allergy Relief

Additional Skin Therapies

1 Anti-itch Drugs Market Overview
1.1 Product Definition
1.2 Anti-itch Drugs by Type
1.2.1 Global Anti-itch Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Preparation
1.2.3 Compound Ointment
1.3 Anti-itch Drugs by Application
1.3.1 Global Anti-itch Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Anti-itch Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-itch Drugs Revenue 2020-2031
1.4.2 Global Anti-itch Drugs Sales 2020-2031
1.4.3 Global Anti-itch Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-itch Drugs Market Competition by Manufacturers
2.1 Global Anti-itch Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-itch Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-itch Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-itch Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-itch Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-itch Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-itch Drugs, Date of Enter into This Industry
2.8 Global Anti-itch Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-itch Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-itch Drugs Players Market Share by Revenue
2.8.3 Global Anti-itch Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-itch Drugs Market Scenario by Region
3.1 Global Anti-itch Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-itch Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-itch Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-itch Drugs Sales by Region: 2026-2031
3.3 Global Anti-itch Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-itch Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-itch Drugs Revenue by Region: 2026-2031
3.4 North America Anti-itch Drugs Market Facts & Figures by Country
3.4.1 North America Anti-itch Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-itch Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-itch Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-itch Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-itch Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-itch Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-itch Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-itch Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-itch Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-itch Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-itch Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-itch Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-itch Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-itch Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-itch Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-itch Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-itch Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-itch Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-itch Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-itch Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-itch Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-itch Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-itch Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-itch Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-itch Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-itch Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-itch Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-itch Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-itch Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-itch Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-itch Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-itch Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-itch Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-itch Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-itch Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-itch Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-itch Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Anti-itch Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Anti-itch Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Anti-itch Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Combe Incorporated
6.4.1 Combe Incorporated Company Information
6.4.2 Combe Incorporated Description and Business Overview
6.4.3 Combe Incorporated Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Combe Incorporated Anti-itch Drugs Product Portfolio
6.4.5 Combe Incorporated Recent Developments/Updates
6.5 CR SANJIU
6.5.1 CR SANJIU Company Information
6.5.2 CR SANJIU Description and Business Overview
6.5.3 CR SANJIU Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CR SANJIU Anti-itch Drugs Product Portfolio
6.5.5 CR SANJIU Recent Developments/Updates
6.6 Lingrui
6.6.1 Lingrui Company Information
6.6.2 Lingrui Description and Business Overview
6.6.3 Lingrui Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lingrui Anti-itch Drugs Product Portfolio
6.6.5 Lingrui Recent Developments/Updates
6.7 Jinyao Pharma
6.7.1 Jinyao Pharma Company Information
6.7.2 Jinyao Pharma Description and Business Overview
6.7.3 Jinyao Pharma Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jinyao Pharma Anti-itch Drugs Product Portfolio
6.7.5 Jinyao Pharma Recent Developments/Updates
6.8 Dinuo Pharma
6.8.1 Dinuo Pharma Company Information
6.8.2 Dinuo Pharma Description and Business Overview
6.8.3 Dinuo Pharma Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dinuo Pharma Anti-itch Drugs Product Portfolio
6.8.5 Dinuo Pharma Recent Developments/Updates
6.9 Huapont
6.9.1 Huapont Company Information
6.9.2 Huapont Description and Business Overview
6.9.3 Huapont Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Huapont Anti-itch Drugs Product Portfolio
6.9.5 Huapont Recent Developments/Updates
6.10 Medimetriks Pharmaceuticals
6.10.1 Medimetriks Pharmaceuticals Company Information
6.10.2 Medimetriks Pharmaceuticals Description and Business Overview
6.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolio
6.10.5 Medimetriks Pharmaceuticals Recent Developments/Updates
6.11 Taro Pharmaceutical
6.11.1 Taro Pharmaceutical Company Information
6.11.2 Taro Pharmaceutical Description and Business Overview
6.11.3 Taro Pharmaceutical Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Taro Pharmaceutical Anti-itch Drugs Product Portfolio
6.11.5 Taro Pharmaceutical Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Teva Anti-itch Drugs Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Sun Pharmaceutical
6.13.1 Sun Pharmaceutical Company Information
6.13.2 Sun Pharmaceutical Description and Business Overview
6.13.3 Sun Pharmaceutical Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sun Pharmaceutical Anti-itch Drugs Product Portfolio
6.13.5 Sun Pharmaceutical Recent Developments/Updates
6.14 Perrigo
6.14.1 Perrigo Company Information
6.14.2 Perrigo Description and Business Overview
6.14.3 Perrigo Anti-itch Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Perrigo Anti-itch Drugs Product Portfolio
6.14.5 Perrigo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-itch Drugs Industry Chain Analysis
7.2 Anti-itch Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-itch Drugs Production Mode & Process Analysis
7.4 Anti-itch Drugs Sales and Marketing
7.4.1 Anti-itch Drugs Sales Channels
7.4.2 Anti-itch Drugs Distributors
7.5 Anti-itch Drugs Customer Analysis
8 Anti-itch Drugs Market Dynamics
8.1 Anti-itch Drugs Industry Trends
8.2 Anti-itch Drugs Market Drivers
8.3 Anti-itch Drugs Market Challenges
8.4 Anti-itch Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-itch Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-itch Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-itch Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-itch Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-itch Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-itch Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-itch Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-itch Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-itch Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-itch Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-itch Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-itch Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-itch Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-itch Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-itch Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-itch Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti-itch Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-itch Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti-itch Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-itch Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-itch Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-itch Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-itch Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-itch Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-itch Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti-itch Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti-itch Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-itch Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-itch Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-itch Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti-itch Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti-itch Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-itch Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-itch Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-itch Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti-itch Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti-itch Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-itch Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-itch Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-itch Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti-itch Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti-itch Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-itch Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-itch Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-itch Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti-itch Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti-itch Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-itch Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-itch Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti-itch Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti-itch Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-itch Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-itch Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-itch Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-itch Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-itch Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-itch Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Anti-itch Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Anti-itch Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti-itch Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti-itch Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-itch Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-itch Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-itch Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-itch Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-itch Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-itch Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Anti-itch Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Anti-itch Drugs Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bayer Anti-itch Drugs Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Anti-itch Drugs Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Combe Incorporated Company Information
 Table 86. Combe Incorporated Description and Business Overview
 Table 87. Combe Incorporated Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Combe Incorporated Anti-itch Drugs Product
 Table 89. Combe Incorporated Recent Developments/Updates
 Table 90. CR SANJIU Company Information
 Table 91. CR SANJIU Description and Business Overview
 Table 92. CR SANJIU Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CR SANJIU Anti-itch Drugs Product
 Table 94. CR SANJIU Recent Developments/Updates
 Table 95. Lingrui Company Information
 Table 96. Lingrui Description and Business Overview
 Table 97. Lingrui Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lingrui Anti-itch Drugs Product
 Table 99. Lingrui Recent Developments/Updates
 Table 100. Jinyao Pharma Company Information
 Table 101. Jinyao Pharma Description and Business Overview
 Table 102. Jinyao Pharma Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jinyao Pharma Anti-itch Drugs Product
 Table 104. Jinyao Pharma Recent Developments/Updates
 Table 105. Dinuo Pharma Company Information
 Table 106. Dinuo Pharma Description and Business Overview
 Table 107. Dinuo Pharma Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Dinuo Pharma Anti-itch Drugs Product
 Table 109. Dinuo Pharma Recent Developments/Updates
 Table 110. Huapont Company Information
 Table 111. Huapont Description and Business Overview
 Table 112. Huapont Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Huapont Anti-itch Drugs Product
 Table 114. Huapont Recent Developments/Updates
 Table 115. Medimetriks Pharmaceuticals Company Information
 Table 116. Medimetriks Pharmaceuticals Description and Business Overview
 Table 117. Medimetriks Pharmaceuticals Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Medimetriks Pharmaceuticals Anti-itch Drugs Product
 Table 119. Medimetriks Pharmaceuticals Recent Developments/Updates
 Table 120. Taro Pharmaceutical Company Information
 Table 121. Taro Pharmaceutical Description and Business Overview
 Table 122. Taro Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Taro Pharmaceutical Anti-itch Drugs Product
 Table 124. Taro Pharmaceutical Recent Developments/Updates
 Table 125. Teva Company Information
 Table 126. Teva Description and Business Overview
 Table 127. Teva Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Teva Anti-itch Drugs Product
 Table 129. Teva Recent Developments/Updates
 Table 130. Sun Pharmaceutical Company Information
 Table 131. Sun Pharmaceutical Description and Business Overview
 Table 132. Sun Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sun Pharmaceutical Anti-itch Drugs Product
 Table 134. Sun Pharmaceutical Recent Developments/Updates
 Table 135. Perrigo Company Information
 Table 136. Perrigo Description and Business Overview
 Table 137. Perrigo Anti-itch Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Perrigo Anti-itch Drugs Product
 Table 139. Perrigo Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Anti-itch Drugs Distributors List
 Table 143. Anti-itch Drugs Customers List
 Table 144. Anti-itch Drugs Market Trends
 Table 145. Anti-itch Drugs Market Drivers
 Table 146. Anti-itch Drugs Market Challenges
 Table 147. Anti-itch Drugs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-itch Drugs
 Figure 2. Global Anti-itch Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-itch Drugs Market Share by Type: 2024 & 2031
 Figure 4. Single Preparation Product Picture
 Figure 5. Compound Ointment Product Picture
 Figure 6. Global Anti-itch Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti-itch Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Anti-itch Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Anti-itch Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Anti-itch Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Anti-itch Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 15. Anti-itch Drugs Report Years Considered
 Figure 16. Anti-itch Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Anti-itch Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Anti-itch Drugs Players: Market Share by Revenue in Anti-itch Drugs in 2024
 Figure 19. Anti-itch Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Anti-itch Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Anti-itch Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Anti-itch Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Anti-itch Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Anti-itch Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Anti-itch Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Anti-itch Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Anti-itch Drugs Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Anti-itch Drugs Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Anti-itch Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Anti-itch Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Anti-itch Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Anti-itch Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Anti-itch Drugs by Type (2020-2031)
 Figure 54. Global Anti-itch Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Anti-itch Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Anti-itch Drugs by Application (2020-2031)
 Figure 57. Global Anti-itch Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Anti-itch Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart